Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leptin Replacement in Lipodystrophy
NCT00896298Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2006
- Primary completion
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of metreleptin in generalized lipodystrophy (GL), familial partial lipodystrophy (FPLD), sponsored by UT Southwestern Medical Center. Started Apr 2006; status: completed.
02
Drugs
metreleptin
03
Conditions
generalized lipodystrophy (GL)familial partial lipodystrophy (FPLD)
Beyond the preview
Go deeper on NCT00896298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896298.